WHO: Russia Shared Data on Phase I, II Clinical Trials of COVID-19 Vaccine Sputnik V
Russia has shared with the World Health Organisation (WHO) the data obtained during phase I and II of the clinical trials of its Sputnik V vaccine against COVID-19, an adviser at the WHO’s Western Pacific Regional Office said.
“On the Russian vaccine again, this is an update from the last briefing. During that time, it was a very early stage of discussion between the WHO and the regulatory authority of Russia, and now we know that Russia has already shared their data for the phase I and phase II clinical trial with the WHO, and the Russian national regulatory authority itself has already given conditional approval for the vaccine. Beyond that, we do not have information yet as to the deployment of these vaccines in other countries”, Dr Socorro Escalante said at a briefing.